Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ROS/KRAS/AMPK Signaling Contributes to Gemcitabine-Induced Stem-like Cell Properties in Pancreatic Cancer
Hengqiang Zhao, Shihong Wu, Hehe Li, et al.
Molecular Therapy — Oncolytics (2019) Vol. 14, pp. 299-312
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

The Role of Oxidative Stress in Tumorigenesis and Progression
Kexin Li, Zhangyuzi Deng, Chunran Lei, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 441-441
Open Access | Times Cited: 23
Emerging role of NRF2 in ROS-mediated tumor chemoresistance
Danfeng Xue, Xiongming Zhou, Jiaxuan Qiu
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110676-110676
Open Access | Times Cited: 139
Metabolic Heterogeneity of Cancer Cells: An Interplay between HIF-1, GLUTs, and AMPK
Nurbubu T. Moldogazieva, Innokenty M. Mokhosoev, Alexander A. Terentiev
Cancers (2020) Vol. 12, Iss. 4, pp. 862-862
Open Access | Times Cited: 136
Dual Role of Reactive Oxygen Species and their Application in Cancer Therapy
Run Huang, Huan Chen, Jiayu Liang, et al.
Journal of Cancer (2021) Vol. 12, Iss. 18, pp. 5543-5561
Open Access | Times Cited: 103
Reactive oxygen species (ROS) in cancer pathogenesis and therapy: An update on the role of ROS in anticancer action of benzophenanthridine alkaloids
Abdul Quaiyoom Khan, Khalid Rashid, Abdulhadi A. AlAmodi, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112142-112142
Open Access | Times Cited: 100
ROS and TGFβ: from pancreatic tumour growth to metastasis
Chao‐Hui Chang, Siim Pauklin
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 66
Control of Oxidative Stress in Cancer Chemoresistance: Spotlight on Nrf2 Role
Giuseppina Barrera, Marie Angèle Cucci, Margherita Grattarola, et al.
Antioxidants (2021) Vol. 10, Iss. 4, pp. 510-510
Open Access | Times Cited: 64
Natural product manoalide promotes EGFR-TKI sensitivity of lung cancer cells by KRAS-ERK pathway and mitochondrial Ca2+ overload-induced ferroptosis
Yinyun Ni, Jiaye Liu, Lingyan Zeng, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 19
The effects of mutant Ras proteins on the cell signalome
Tamás Takács, Gyöngyi Kudlik, Anita Kurilla, et al.
Cancer and Metastasis Reviews (2020) Vol. 39, Iss. 4, pp. 1051-1065
Open Access | Times Cited: 49
LINC00680 enhances hepatocellular carcinoma stemness behavior and chemoresistance by sponging miR-568 to upregulate AKT3
Gege Shu, Huizhao Su, Zhiqian Wang, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 36
Autophagy: A Key Player in Pancreatic Cancer Progression and a Potential Drug Target
Josef Gillson, Yomna S. Abd El-Aziz, Lionel Yi Wen Leck, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3528-3528
Open Access | Times Cited: 27
Pancreatic stellate cell-induced gemcitabine resistance in pancreatic cancer is associated with LDHA- and MCT4-mediated enhanced glycolysis
Manoj Amrutkar, Kjersti Berg, Aina Balto, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Pharmacological Insights: Mitochondrial ROS Generation by FNC (Azvudine) in Dalton’s Lymphoma Cells Revealed by Super Resolution Imaging
Naveen Kumar, Vikram Delu, Ilya V. Ulasov, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 2, pp. 873-883
Closed Access | Times Cited: 6
An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness
Mei-Yu Quan, Qiang Guo, Jiayu Liu, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 39
Hyperglycemia Enhances Immunosuppression and Aerobic Glycolysis of Pancreatic Cancer Through Upregulating Bmi1-UPF1-HK2 Pathway
Shihong Wu, Haoxiang Zhang, Chenggang Gao, et al.
Cellular and Molecular Gastroenterology and Hepatology (2022) Vol. 14, Iss. 5, pp. 1146-1165
Open Access | Times Cited: 21
A Brief Review on Chemoresistance; Targeting Cancer Stem Cells as an Alternative Approach
Belén Toledo, Aitor González-Titos, Pablo Hernández-Camarero, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4487-4487
Open Access | Times Cited: 12
Cancer Stem Cell (CSC) Inhibitors in Oncology—A Promise for a Better Therapeutic Outcome: State of the Art and Future Perspectives
Prashant S. Kharkar
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 24, pp. 15279-15307
Closed Access | Times Cited: 32
Pancreatic Cancer (PDAC): Introduction of Evidence-Based Complementary Measures into Integrative Clinical Management
Valerie Jentzsch, James A. Davis, Mustafa B.A. Djamgoz
Cancers (2020) Vol. 12, Iss. 11, pp. 3096-3096
Open Access | Times Cited: 31
Pancreatic cancer stem cell-derived exosomal miR-210 mediates macrophage M2 polarization and promotes gemcitabine resistance by targeting FGFRL1
Yao Guo, Jing Cui, Xueyi Liang, et al.
International Immunopharmacology (2023) Vol. 127, pp. 111407-111407
Open Access | Times Cited: 11
FTO-mediated LINC01134 stabilization to promote chemoresistance through miR-140-3p/WNT5A/WNT pathway in PDAC
Lu Jin, Yongsheng Yang, Xiangliang Liu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 11
Open Access | Times Cited: 10
KRAS Inhibition Reverses Chemotherapy Resistance Promoted by Therapy-Induced Senescence-like in Pancreatic Ductal Adenocarcinoma
Analía Meilerman Abuelafia, Patricia Santofimia‐Castaño, Matías Estarás, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
KRAS inhibition reverses chemotherapy resistance promoted by therapy-induced senescence-like in pancreatic ductal adenocarcinoma
Analía Meilerman Abuelafia, Patricia Santofimia‐Castaño, Matías Estarás, et al.
Translational Oncology (2025) Vol. 57, pp. 102421-102421
Open Access
The KRAS/Lin28B axis maintains stemness of pancreatic cancer cells via the let‐7i/TET3 pathway
Yawen Liu, Dawei Wang, Meng Zhou, et al.
Molecular Oncology (2020) Vol. 15, Iss. 1, pp. 262-278
Open Access | Times Cited: 25
4‑Acetylantroquinonol B enhances cell death and inhibits autophagy by downregulating the PI3K/Akt/MDR1 pathway in gemcitabine‑resistant pancreatic cancer cells
Ying‐Yin Chen, Sheng-Yi Chen, Tsung‐Ju Li, et al.
Oncology Letters (2022) Vol. 23, Iss. 4
Open Access | Times Cited: 13
Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell Lines
Yixuan Ma, Benjamin Schulz, Nares Trakooljul, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4467-4467
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top